A Diffuse Optical Spectroscopy’s Time Domain Optical Molecular system, non-invasive SoftScan® delivers pathophysiological changes + functional data at molecular level before they can be anatomically seen: Detects much earlier lesions and characterizes tissue without recourse to biopsy – Allows prediction of chemoresponse before treatment initiation – Earliest monitoring of therapeutic efficacy/non-efficacy of treatment administered to patient – Real time non-invasive “soft” customization of breast cancer treatments. Applicable to other body parts and diseases.
Company’s Keywords:
<1
<
<
Your request has been submitted successfully.
Own or work here?